Autoantibody biomarkers identified and validated using Sengenics protein arrays have shown utility in a range of high-value applications—from early disease detection and patient stratification to treatment monitoring and prediction of treatment outcomes and immune-related adverse events (irAE).
Learn more about key applications for Sengenics technology and services.
Biomarker Discovery and Validation
Identification of autoantibody biomarker
signatures.
Patient Stratification
Intra-disease stratification, identification of cohorts and clinical trial patient enrichment.
